PUBLIC CONTRACT · 2025

10E0188325 | Aquisição de AVACOPANO ORAL 10MG CAP, AUE no 202401326, ao Lab. VIFOR PHARMA PORTUGAL, S.A., para a ULSASI, para o ano 2025

Contract value
€77,263.20
Signed on
17 February 2025
Procedure
Contratação excluída II

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 15491908

PUBLISHED SUBJECT

10E0188325 | Aquisição de AVACOPANO ORAL 10MG CAP, AUE no 202401326, ao Lab. VIFOR PHARMA PORTUGAL, S.A., para a ULSASI, para o ano 2025

WHO CONTRACTED

Parties involved

Place of performance
Portugal, Lisboa, Amadora
NUTS region
PT1A0 - Grande Lisboa

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
VIFOR PHARMA PORTUGAL, S.A. · Tax ID 516677586

HOW MUCH AND WHEN

Values and timeline

Contract price
€77,263.20
Procedure base price
€77,263.20
Total effective price
Not reported on Portal BASE
Publication date
13 August 2026
Award date
17 February 2025
Signing date
17 February 2025
Performance period
317 days

The contract price is the value agreed in the contract, not the amount paid.

HOW IT WAS CONTRACTED

Procedure and framework

Contract type
Aquisição de bens móveis
Procedure type
Contratação excluída II
Award criterion
Monofator
CPV code
33600000-6 - Produtos farmacêuticos
Legal basis
artigo 5.º n.º 1 do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
Framework agreement
Not stated
Centralised procedure
No
Environmental criterion
No
Notice
Not stated
Procedure identifier
7474690

KEEP EXPLORING

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts